Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global disinfecting medical equipment market was valued at USD 1.18 billion in 2024 and is projected to reach USD 1.69 billion by 2031, exhibiting a CAGR of 5.3% during the forecast period.
Disinfecting medical equipment refers to specialized devices and solutions designed to eliminate or reduce pathogenic microorganisms on medical surfaces and equipment. These systems utilize various technologies including steam sterilization, dry heat disinfection, chemical disinfection, ultraviolet radiation, and plasma-based systems to ensure thorough decontamination of medical instruments and environments.
Market growth is primarily driven by increasing surgical volumes globally, with the World Health Organization reporting over 310 million major surgeries performed annually. Additionally, growing awareness of hospital-acquired infections (HAIs) affecting approximately 7% of hospitalized patients in developed countries contributes to demand. The COVID-19 pandemic accelerated adoption rates, with hospital disinfection equipment demand increasing by 37% during 2020-2022 according to WHO assessments.
North America currently dominates the market with 38% revenue share, followed by Europe at 31%, while Asia-Pacific shows the strongest growth potential with 12.3% CAGR projection through 2031. Market leaders include STERIS Corporation, Getinge Group, and Ecolab, who collectively hold approximately 42% market share through their comprehensive product portfolios and global service networks.
Regulatory standards continue to evolve with the U.S. FDA strengthening guidelines on reprocessing medical devices, while the EU Medical Device Regulation imposes stricter requirements on sterilization validation. These regulatory developments are creating both opportunities and challenges for market participants.
Rising Healthcare-Associated Infections (HAIs) Drive Demand
The global increase in healthcare-associated infections, particularly in surgical and intensive care settings, has created unprecedented demand for effective medical equipment disinfection solutions. Hospitals and clinics are investing heavily in advanced disinfection technologies to meet accreditation requirements and improve patient safety metrics.
Pandemic Preparedness and Infrastructure Upgrades
Following the COVID-19 pandemic, healthcare facilities worldwide are upgrading their infection control infrastructure with substantial budget allocations. Governments are allocating funds specifically for hospital disinfection capabilities, with a 2023 global investment increase of 34% compared to pre-pandemic levels for infection control equipment.
➤ Countries are implementing stricter regulations for medical equipment sterilization, mandating higher standards that require advanced disinfection technologies
The shift toward single-use medical devices in some sectors has paradoxically increased demand for high-level disinfection of reusable equipment, as facilities seek to balance cost containment with infection control requirements.
MARKET CHALLENGES
High Implementation and Maintenance Costs
Advanced disinfection systems, particularly ultraviolet (UV) and hydrogen peroxide vapor technologies, require significant capital investment. Many smaller healthcare facilities, especially in developing regions, face budget constraints that limit adoption. Maintenance contracts and consumable costs add ongoing expenses that some facilities cannot sustain long-term.
Other Challenges
Resistance Development and Efficacy Validation
The rapid evolution of multi-drug resistant organisms creates constant pressure on disinfection technology efficacy. Validating that new systems effectively eliminate emerging threats requires continuous investment in testing and quality assurance, adding operational complexity and cost.
Supply Chain and Raw Material Constraints
Global supply chain disruptions continue to affect the availability of key components for advanced disinfection systems, particularly semiconductors for UV systems and specialized alloys for sterilization equipment. These constraints have extended delivery times by an average of 3-4 months and increased costs by approximately 22% in the past 18 months, affecting implementation timelines for healthcare facility upgrades.
Emerging Markets and Technology Integration
The Asia-Pacific region, particularly India and Southeast Asian countries, shows the fastest growth in healthcare infrastructure development. These markets present opportunities for both basic and advanced disinfection systems as new hospitals are built and older facilities are upgraded to international standards. The market is expected to grow at 11.3% CAGR in these regions through 2028.
Robotics and Automation Integration
Integration of disinfection systems with robotic surgical platforms and automated hospital systems creates new market segments. The need for real-time disinfection in robotic surgery and automated patient care environments is driving innovation in compact, integrated disinfection solutions that can operate within larger automated systems.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Liquid Disinfectants remain the dominant segment due to their versatility across different healthcare settings, cost-effectiveness for large-scale disinfection, and established protocols for their application across various medical equipment types. |
| By Application |
|
Hospital Surfaces and Equipment segment leads due to the critical need for infection control in high-risk areas, regulatory compliance requirements, and the constant flow of patients requiring rigorous disinfection protocols for all equipment and surfaces. |
| By End User |
|
Hospitals and Clinics dominate due to their high patient volume, diverse range of equipment requiring disinfection, stringent regulatory standards, and dedicated infection control teams that systematically implement disinfection protocols across all departments. |
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The global disinfecting medical equipment market is dominated by several key multinational corporations, with STERIS plc (US) holding the largest market share through its comprehensive portfolio of sterilization equipment, consumables, and monitoring products. The market is highly competitive with major players focusing on technological innovation, regulatory compliance, and strategic partnerships to maintain their market position.
Other significant players include Cantel Medical Corp. (US), which specializes in infection prevention products and has strong presence in endoscopy and dialysis disinfection systems. Getinge Group (Sweden) maintains strong market position through its advanced sterilization systems and comprehensive service networks across Europe and North America. Advanced Sterilization Products (US), a division of Johnson & Johnson, focuses specifically on high-level disinfection and sterilization solutions with strong growth in emerging markets.
Market leaders are aggressively expanding their product portfolios through both organic R&D and strategic acquisitions. STERIS recently acquired Key Surgical to strengthen its presence in the sterile processing and endoscopy markets. Similarly, Cantenac has been actively acquiring smaller specialized manufacturers to expand their technological capabilities and geographic reach, particularly in the rapidly growing Asian markets.
Companies are increasingly investing in developing environmentally friendly disinfection technologies and automated systems that reduce human intervention. The shift towards automated endoscope reprocessors and hydrogen peroxide sterilization systems represents the latest technological frontier, with companies competing to offer more efficient, cost-effective, and environmentally sustainable solutions to healthcare facilities.
List of Key Disinfecting Medical Equipment Companies ProfiledSTERIS plc (USA)
Cantel Medical Corp. (USA)
Getinge Group (Sweden)
Advanced Sterilization Products (USA)
STERIS Limited (UK)
Getinge Infection Control (Sweden)
Hospitals and healthcare facilities are increasingly adopting UV-C disinfection systems as a complementary method to traditional cleaning. The technology offers rapid disinfection cycles (under 5 minutes per room) and effectively eliminates up to 99.9% of pathogens including C. difficile and MRSA. This has driven market growth of 12.4% annually since 2020, with projections indicating sustained demand through 2030.
Other TrendsPortable and Handheld Disinfection Equipment
The market for portable UV-C and electrostatic sprayers has expanded significantly, particularly for use in ambulances, dental clinics, and outpatient facilities. These devices address the need for rapid decontamination between patient visits and in spaces where fixed installations are impractical. Sales of portable units grew by 18% in 2023 alone, reflecting increased focus on point-of-care infection control.
Advanced disinfection systems now incorporate IoT sensors to monitor usage, UV intensity, and equipment status in real-time. This enables predictive maintenance and ensures consistent disinfection efficacy. Facilities using smart-connected systems report 30% fewer HAIs (Healthcare-Associated Infections) compared to traditional methods. The data collection also provides valuable insights for optimizing disinfection protocols across different healthcare settings.
Specialized equipment has emerged for different surface types. Antimicrobial LED lighting integrated into surgical suites provides continuous disinfection of air and surfaces. For complex equipment like ventilators and dialysis machines, manufacturers now offer proprietary disinfection systems that integrate directly with the equipment. These developments address the challenge of disinfecting sensitive electronic components that cannot tolerate liquid disinfectants.
Regulatory agencies have updated guidelines to include these new technologies, with CDC and EPA releasing interim guidance on UV-C dosage and exposure times. This has accelerated adoption as facilities seek compliance with updated standards.
Regional Analysis: Disinfecting Medical Equipment MarketEurope
European markets show strong growth in automated endoscope reprocessors and UV disinfection systems. Germany leads with largest number of installations followed by France and UK. Eastern European countries show preference for mid-range equipment while Western Europe adopts higher-end automated systems. EU funding for hospital upgrades in newer member states contributes to market growth alongside aging population and surgical procedure increases.
Asia-Pacific
Asia-Pacific represents both the largest and fastest growing region with China, Japan and South Korea comprising the majority market share. India shows strongest growth rate with healthcare infrastructure development driving demand across all equipment categories. ASEAN countries show preference for Japanese and Korean equipment while Australia implements similar standards to North America. Regional healthcare cooperation initiatives boost cross-border technology transfer and adoption.
Latin America
Latin American markets show recovery from economic challenges with Brazil, Mexico and Argentina as primary markets. Mexican manufacturing capabilities support local production of certain equipment categories. Brazil shows strength in chemical-based systems while Argentina leads in UV equipment. Chile and Colombia show fastest growth rates with Peru and Venezuela showing recovery. Regional trade agreements facilitate cross-border equipment movement.
Middle East & Africa
Middle Eastern markets show strongest growth in UAE and Saudi Arabia where hospital construction projects drive demand. Qatar shows similar growth patterns with smaller GCC countries following. African markets led by South Africa, Egypt and Nigeria show preference for cost-effective chemical and UV systems with South Africa showing strongest growth in automated systems. North African markets show preference for European-manufactured equipment.
This report offers a comprehensive view of the global Disinfecting Medical Equipment market with data from 2020 to 2031. It presents accurate and actionable insights based on a combination of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By technology type (steam, dry heat, chemical)
By application area (hospital, clinic, others)
By distribution channel and end-user segment
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets including US, Canada, Germany, UK, Japan, China, Brazil
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: partnerships, expansions, new product development
Product portfolio and pricing strategy analysis
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation and digitalization features
Impact of IoT and smart technologies
✅ Market Dynamics
Key growth drivers and market opportunities
Restraints and potential risk factors
Supply chain and regulatory impacts
✅ Opportunities & Recommendations
High-growth segments and emerging markets
Investment opportunities and strategic recommendations
Future outlook and strategic planning insights
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Medical device manufacturers and suppliers
Healthcare facility administrators and procurement specialists
Infection control professionals and hospital administrators
Investors, consultants, and policy makers
-> The global disinfecting medical equipment market was valued at USD 1.18 billion in 2024 and is projected to reach USD 1.69 billion by 2031.
-> The market is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.
-> Asia-Pacific shows the highest growth potential with increasing healthcare expenditure, while North America continues to hold the largest market share due to strict regulations and advanced healthcare infrastructure.
-> Key drivers include: Increasing surgical volumes globally (over 310 million major surgeries annually), rising awareness of hospital-acquired infections (affecting 7% of hospitalized patients in developed countries), stringent regulatory requirements for sterilization and disinfection, and the ongoing impact of COVID-19 pandemic that increased demand by 37% during 2020-2022.
-> Market leaders include 3M Company, STERIS, Getinge Group, Ecolab, Advanced Sterilization Products, Metrex Research, Cantel Medical Corporation, Ruhof Corporation, BODE Chemie, Integra LifeSciences, among others. These companies collectively hold significant market share through comprehensive product portfolios and global service networks.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates